Table 5.
Comparison of cardiovascular adverse events 3 months after surgery among the three groups (n(%)).
| Group | Heart failure | Ventricular fibrillation | Death | Total incidence of cardiovascular adverse events |
|---|---|---|---|---|
| Group A (n = 28) | 3 (10.71) | 0 (0.00) | 0 (0.00) | 3 (10.71)c |
| Group B (n = 28) | 4 (14.29) | 2 (7.14) | 1 (3.57) | 7 (25.00)c |
| Group C (n = 28) | 9 (32.14) | 3 (10.71) | 3 (10.71) | 15 (53.57) |
aSame group comparison before treatment (P < 0.05). bComparison with group B (P < 0.05). cComparison with group C (P < 0.05).